Bill Text: NJ S2089 | 2018-2019 | Regular Session | Introduced


Bill Title: Prohibits pharmacies from charging additional fee for processing prescriptions transmitted by telephone or electronic means.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Introduced - Dead) 2018-03-05 - Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee [S2089 Detail]

Download: New_Jersey-2018-S2089-Introduced.html

SENATE, No. 2089

STATE OF NEW JERSEY

218th LEGISLATURE

 

INTRODUCED MARCH 5, 2018

 


 

Sponsored by:

Senator  JAMES BEACH

District 6 (Burlington and Camden)

 

 

 

 

SYNOPSIS

     Prohibits pharmacies from charging additional fee for processing prescriptions transmitted by telephone or electronic means.

 

CURRENT VERSION OF TEXT

     As introduced.

  


An Act concerning electronic prescriptions and amending P.L.2003, c.280.

 

     Be It Enacted by the Senate and General Assembly of the State of New Jersey:

 

     1.    Section 19 of P.L.2003, c.280 (C.45:14-58) is amended to read as follows:

     19.  a.  Nothing contained in this act shall preclude a practitioner from transmitting to a pharmacist by telephone or electronic means a prescription, as otherwise authorized by law, if that practitioner provides the practitioner's Drug Enforcement Administration registration number and the practitioner's license number, or any other federally identified number, as appropriate, to the pharmacist at the time the practitioner transmits the prescription.  A pharmacist shall not charge any fee for processing a prescription transmitted by telephone or electronic means unless the fee is also charged for processing a prescription transmitted in writing.

     b.    Except as may be otherwise permitted by law, no prescription for any Schedule II controlled dangerous substance shall be given or transmitted to pharmacists, in any other manner, than in writing signed by the practitioner giving or transmitting the same, nor shall such prescription be renewed or refilled.  The requirement in this subsection that a prescription for any controlled dangerous substance be given or transmitted to pharmacists in writing signed by the practitioner shall not apply to a prescription for a Schedule II drug if that prescription is transmitted or prepared in compliance with federal and State regulations.

(cf: P.L.2003, c.280, s.19)

 

     2.    This act shall take effect immediately.

 

 

STATEMENT

 

     This bill would prohibit pharmacists from charging additional fees for processing prescriptions that are transmitted by telephone or electronic means unless the fees also apply to prescriptions transmitted in writing.  It is the Sponsor's belief that electronically-transmitted prescriptions are more efficient than written prescriptions, and that imposing additional processing fees may discourage the use of electronic prescriptions.   

feedback